These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 34310804)

  • 21. miR-206 functions as a novel cell cycle regulator and tumor suppressor in clear-cell renal cell carcinoma.
    Xiao H; Xiao W; Cao J; Li H; Guan W; Guo X; Chen K; Zheng T; Ye Z; Wang J; Xu H
    Cancer Lett; 2016 Apr; 374(1):107-116. PubMed ID: 26808577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TSP50 promotes hepatocyte proliferation and tumour formation by activating glucose-6-phosphate dehydrogenase (G6PD).
    Zhang X; Gao F; Ai H; Wang S; Song Z; Zheng L; Wang G; Sun Y; Bao Y
    Cell Prolif; 2021 Apr; 54(4):e13015. PubMed ID: 33630390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
    Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
    Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. G6PD downregulation triggered growth inhibition and induced apoptosis by regulating STAT3 signaling pathway in esophageal squamous cell carcinoma.
    Wang X; Liu H; Zhang X; Li X; Gu H; Zhang H; Fan R
    Tumour Biol; 2016 Jan; 37(1):781-9. PubMed ID: 26250461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. YAP is overexpressed in clear cell renal cell carcinoma and its knockdown reduces cell proliferation and induces cell cycle arrest and apoptosis.
    Cao JJ; Zhao XM; Wang DL; Chen KH; Sheng X; Li WB; Li MC; Liu WJ; He J
    Oncol Rep; 2014 Oct; 32(4):1594-600. PubMed ID: 25175178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain-dependent regulation of Wnt/β-catenin signaling.
    Chen L; Xie Y; Ma X; Zhang Y; Li X; Zhang F; Gao Y; Fan Y; Gu L; Wang L; Zhang X; Fu B
    Mol Carcinog; 2020 Oct; 59(10):1159-1173. PubMed ID: 32794610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GYS1 induces glycogen accumulation and promotes tumor progression via the NF-κB pathway in Clear Cell Renal Carcinoma.
    Chen SL; Huang QS; Huang YH; Yang X; Yang MM; He YF; Cao Y; Guan XY; Yun JP
    Theranostics; 2020; 10(20):9186-9199. PubMed ID: 32802186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of
    Ma Z; Qi Z; Shan Z; Li J; Yang J; Xu Z
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28923830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
    Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
    Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NAT10-mediated ac
    Miao D; Shi J; Lv Q; Tan D; Zhao C; Xiong Z; Zhang X
    Cancer Commun (Lond); 2024 Mar; 44(3):361-383. PubMed ID: 38407929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA SNHG6 promotes carcinogenesis by enhancing YBX1-mediated translation of HIF1α in clear cell renal cell carcinoma.
    Zhao P; Deng Y; Wu Y; Guo Q; Zhou L; Yang X; Wang C
    FASEB J; 2021 Feb; 35(2):e21160. PubMed ID: 33150667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ATXN3 promotes proliferation, stemness and motility of clear cell renal cell carcinoma cells by regulating S100A8 ubiquitination.
    Bai J; Han J; Fan J; Song J; Wang S
    Physiol Int; 2023 Dec; 110(4):311-325. PubMed ID: 37938238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of SAV1 plays a role in pathogenesis of high-grade clear cell renal cell carcinoma.
    Matsuura K; Nakada C; Mashio M; Narimatsu T; Yoshimoto T; Tanigawa M; Tsukamoto Y; Hijiya N; Takeuchi I; Nomura T; Sato F; Mimata H; Seto M; Moriyama M
    BMC Cancer; 2011 Dec; 11():523. PubMed ID: 22185343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma.
    Mizutani A; Koinuma D; Seimiya H; Miyazono K
    Oncogene; 2016 Jul; 35(27):3514-23. PubMed ID: 26522722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting NPL4 via drug repositioning using disulfiram for the treatment of clear cell renal cell carcinoma.
    Yoshino H; Yamada Y; Enokida H; Osako Y; Tsuruda M; Kuroshima K; Sakaguchi T; Sugita S; Tatarano S; Nakagawa M
    PLoS One; 2020; 15(7):e0236119. PubMed ID: 32667929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of G6PD acetylation by SIRT2 and KAT9 modulates NADPH homeostasis and cell survival during oxidative stress.
    Wang YP; Zhou LS; Zhao YZ; Wang SW; Chen LL; Liu LX; Ling ZQ; Hu FJ; Sun YP; Zhang JY; Yang C; Yang Y; Xiong Y; Guan KL; Ye D
    EMBO J; 2014 Jun; 33(12):1304-20. PubMed ID: 24769394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-Myc modulates glucose metabolism via regulation of miR-184/PKM2 pathway in clear-cell renal cell carcinoma.
    Huang J; Kong W; Zhang J; Chen Y; Xue W; Liu D; Huang Y
    Int J Oncol; 2016 Oct; 49(4):1569-75. PubMed ID: 27431728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of OCLN and GAS1 in clear cell renal cell carcinoma.
    Conceição AL; Da Silva CT; Badial RM; Valsechi MC; Stuqui B; Gonçalves JD; Jasiulionis MG; De Freitas Calmon M; Rahal P
    Oncol Rep; 2017 Mar; 37(3):1487-1496. PubMed ID: 28184927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic silencing of ASPP1 confers 5-FU resistance in clear cell renal cell carcinoma by preventing p53 activation.
    Wang X; Cheng Y; Zhu Y; Li H; Ge W; Wu X; Zhao K; Yuan J; Li Z; Jiang S; Han Z; Jiang Q; Wu Q; Liu T; Zhang C; Yu M; Hu Y
    Int J Cancer; 2017 Oct; 141(7):1422-1433. PubMed ID: 28656647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PLAGL1 (ZAC1/LOT1) Expression in Clear Cell Renal Cell Carcinoma: Correlations with Disease Progression and Unfavorable Prognosis.
    Godlewski J; Krazinski BE; Kowalczyk AE; Kiewisz J; Kiezun J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Maslowski Z; Kmiec Z
    Anticancer Res; 2016 Feb; 36(2):617-24. PubMed ID: 26851016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.